Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHill & Smith Regulatory News (HILS)

Share Price Information for Hill & Smith (HILS)

Share Price is delayed by 15 minutes
Get Live Data
2,880.00    -5.00 (-0.17%)
Bid:
2,875.00
Ask:
2,880.00
Spread: 5.00 (0.174%)
Market Cap: £2.25b
HILS Live PriceLast checked at - London Stock Exchange

Intraday Hill & Smith Share Chart

Director/PDMR Shareholding

20 Sep 2024 10:57

RNS Number : 0656F
Hill & Smith PLC
20 September 2024
 

Hill & Smith PLC ('Hill & Smith' or 'the Company')

20 September 2024

Grant of Awards under the Hill & Smith 2023 Long-Term Incentive Plan ('LTIP')

On 19 September 2024 (the 'Grant Date') the Company granted an award in the form of a nil cost option over a total of 24,552 ordinary shares in the Company to Rutger Helbing, the Company's Chief Executive Officer, under the LTIP (the 'Award').

The Award will vest based on the achievement of relative Total Shareholder Return (50%) and Underlying EPS Growth (50%) performance conditions measured over a 3-year performance period. The detailed performance conditions will be provided in the 2024 Directors' Remuneration Report.

The Award will (subject to the achievement of the performance conditions) vest following the end of the performance period but will not ordinarily be exercisable until the end of a further two-year holding period.

The number of ordinary shares over which the award was granted was based on a share price of 2,046 pence per ordinary share, being the average mid-market closing share price for the three business days prior to the grant date, as derived from the London Stock Exchange daily official list.

As a result of these transactions Rutger Helbing holds share options over 24,552 ordinary shares in the Company.

 

Enquiries:

Karen Atterbury

Company Secretary

0121 704 7430

 

2024 LTIP Award

1.

Details of the person discharging managerial responsibilities/person closely associated

(a)

Name

Rutger Helbing

2.

Reason for the notification

(a)

Position/status

Chief Executive Officer

(b)

Initial notification/ Amendment

Initial notification

3.

Details of the issuer

(a)

Name

Hill & Smith PLC

(b)

LEI

2138003A3ISGQZBOWI83

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

(a)

Description of the Financial Instrument

Ordinary shares of £0.25 each

Identification code of the Financial Instrument

GB0004270301

(b)

Nature of the transaction

Grant of 2024 LTIP award (in the form of a nil-cost option to acquire ordinary shares in the Company)

(c)

Price(s) and volume(s)

Price(s)

Volume

Nil

24,552

(d)

Aggregated information:

- Aggregated volume

- Price

 

Price(s)

Volume

Nil

24,552

(e)

Date of the transaction

19 September 2024

(f)

Place of the transaction

Outside a trading venue

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHQKKBPCBKKACB
Date   Source Headline
1st Aug 20192:21 pmRNSTotal Voting Rights
22nd Jul 20199:28 amRNSBlock listing Interim Review
3rd Jul 20192:45 pmRNSDirector/PDMR Shareholding
2nd Jul 20197:00 amRNSDirectorate Change
1st Jul 201910:17 amRNSTotal Voting Rights
1st Jul 201910:14 amRNSTotal Voting Rights
3rd Jun 20192:58 pmRNSTotal Voting Rights
17th May 20197:00 amRNSResult of AGM
16th May 20197:00 amRNSAGM Statement
3rd May 201912:15 pmRNSTotal Voting Rights
23rd Apr 201912:17 pmRNSHolding(s) in Company
17th Apr 20193:38 pmRNSHolding(s) in Company
16th Apr 20197:00 amRNSAnnual Report and Notice
8th Apr 20192:59 pmRNSDirector/PDMR Shareholding
2nd Apr 20195:07 pmRNSHolding(s) in Company
2nd Apr 201911:37 amRNSHolding(s) in Company
1st Apr 20194:45 pmRNSDirector/PDMR Shareholding
1st Apr 20194:14 pmRNSTotal Voting Rights
22nd Mar 20198:46 amRNSHolding(s) in Company
20th Mar 20194:54 pmRNSHolding(s) in Company
15th Mar 20196:24 pmRNSDirector/PDMR Shareholding
13th Mar 20192:43 pmRNSDirector/PDMR Shareholding
11th Mar 20194:32 pmRNSDirector/PDMR Shareholding
6th Mar 20197:00 amRNSBoard Changes
6th Mar 20197:00 amRNSFinal Results
4th Mar 201910:28 amRNSTotal Voting Rights
22nd Feb 20197:00 amRNSAcquisition of ATG Access and Debt Facility Update
5th Feb 20197:00 amRNSTotal Voting Rights
21st Jan 20194:55 pmRNSBLOCK LISTING SIX MONTHLY RETURN
7th Jan 20194:24 pmRNSDirector/PDMR Shareholding
7th Jan 20194:22 pmRNSTotal Voting Rights
4th Dec 20187:00 amRNSTotal Voting Rights
22nd Nov 20187:00 amRNSTrading Statement
21st Nov 20184:17 pmRNSHolding(s) in Company
5th Nov 20185:01 pmRNSTotal Voting Rights
30th Oct 20185:04 pmRNSHolding(s) in Company
1st Oct 20182:06 pmRNSTotal Voting Rights
24th Sep 201812:05 pmRNSHolding(s) in Company
14th Sep 201811:25 amRNSHolding(s) in Company
4th Sep 201812:16 pmRNSTotal Voting Rights
29th Aug 20184:32 pmRNSTransaction in Own Shares
23rd Aug 20184:55 pmRNSTransaction in Own Shares
14th Aug 201811:03 amRNSDirector/PDMR Shareholding
9th Aug 20183:16 pmRNSTransaction in Own Shares
9th Aug 201811:52 amRNSDirector/PDMR Shareholding
8th Aug 20186:12 pmRNSDirector/PDMR Shareholding - Replacement
8th Aug 20185:00 pmRNSDirector/PDMR Shareholding
8th Aug 20187:00 amRNSHalf Year Results
2nd Aug 20182:29 pmRNSTotal Voting Rights
1st Aug 20182:34 pmRNSAdditional Listing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.